Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Northwest Biotherapeutics Inc.
DescriptionAutologous dendritic cells treated ex vivo with patient-specific tumor lysates
Molecular Target Not applicable
Mechanism of ActionImmune modulation
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationOvarian cancer
Indication DetailsTreat recurrent ovarian or primary peritoneal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today